Adipotide
Also known as: CKGGRAKDC-GG-D(KLAKLAK)2 · Prohibitin-targeting peptide
An aggressive peptidomimetic that eradicates white fat by destroying the blood supply feeding fat cells. Carries severe renal toxicity risk.
Reviewed by Dr. Sarah Mitchell, PharmD, BCPS
Lead Researcher · 12+ years in peptide therapeutics
~2–4 hours
Research only
Subcutaneous injection
Mechanism of Action
Targets prohibitin on fat vasculature endothelium and delivers a pro-apoptotic sequence that collapses blood supply to adipose tissue.
Key Research Areas
Frequently Asked Questions
What is Adipotide?▾
How does Adipotide work?▾
What is the recommended dosage for Adipotide?▾
What is the half-life of Adipotide?▾
Is Adipotide FDA approved?▾
Research Disclaimer
The information provided about Adipotide is for educational purposes only and is not intended as medical advice. Always consult a qualified healthcare professional before starting any peptide protocol. Products discussed have not been evaluated by the FDA unless explicitly noted.